Cargando…

Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment

OBJECTIVE: Changes in progranulin (GRN) expression have been hypothesized to alter risk for Alzheimer's disease (AD). We investigated the relationship between GRN expression in peripheral blood and clinical diagnosis of AD and mild cognitive impairment (MCI). METHODS: Peripheral blood progranul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Yonatan A., Nachun, Daniel, Dokuru, Deepika, Yang, Zhongan, Karydas, Anna M., Serrero, Ginette, Yue, Binbin, Boxer, Adam L., Miller, Bruce L., Coppola, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945969/ https://www.ncbi.nlm.nih.gov/pubmed/29761124 http://dx.doi.org/10.1002/acn3.560

Ejemplares similares

Signaling Pathway of GP88 (Progranulin) in Breast Cancer Cells: Upregulation and Phosphorylation of c-myc by GP88/Progranulin in Her2-Overexpressing Breast Cancer Cells
por: Kim, Wes E., et al.
Publicado: (2016)

Peripheral blood gene expression reveals an inflammatory transcriptomic signature in Friedreich’s ataxia patients
por: Nachun, Daniel, et al.
Publicado: (2018)

Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects
por: Tkaczuk, Katherine Rak, et al.
Publicado: (2011)

GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells
por: Abrhale, Tesfom, et al.
Publicado: (2011)

Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers
por: Lee, Suzee E., et al.
Publicado: (2019)

Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients
por: Abdulrahman, Amer, et al.
Publicado: (2019)

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
por: Greither, Thomas, et al.
Publicado: (2018)

Progranulin depletion inhibits proliferation via the transforming growth factor beta/SMAD family member 2 signaling axis in Kasumi-1 cells
por: Yabe, Kuniaki, et al.
Publicado: (2021)

Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index
por: Serrero, Ginette, et al.
Publicado: (2016)

Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients
por: Fichte, Alexander, et al.
Publicado: (2022)

Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma
por: Serrero, Ginette, et al.
Publicado: (2012)

Transcriptomic profiling of whole blood in 22q11.2 reciprocal copy number variants reveals that cell proportion highly impacts gene expression
por: Lin, Amy, et al.
Publicado: (2021)

Clinicopathological characteristics and outcomes of gastrointestinal stromal tumors with high progranulin expression
por: Do, In-Gu, et al.
Publicado: (2021)

Elevated levels of extracellular vesicles in progranulin‐deficient mice and FTD‐GRN Patients
por: Arrant, Andrew E., et al.
Publicado: (2020)

Progranulin mutations in clinical and neuropathological Alzheimer's disease
por: Vardarajan, Badri N., et al.
Publicado: (2022)

Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease
por: Yokoyama, Jennifer S, et al.
Publicado: (2015)

An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations
por: Sha, Sharon J., et al.
Publicado: (2017)

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
por: Arrant, Andrew E., et al.
Publicado: (2019)

Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay
por: Nguyen, Andrew D., et al.
Publicado: (2018)

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease
por: De Felice, Bruna, et al.
Publicado: (2020)

Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases
por: Mendsaikhan, Anarmaa, et al.
Publicado: (2019)

Prosaposin is a regulator of progranulin levels and oligomerization
por: Nicholson, Alexandra M., et al.
Publicado: (2016)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
por: Capucho, Patrícia Helena Figueirêdo Vale, et al.
Publicado: (2011)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023)

Effect of Acupuncture in Mild Cognitive Impairment and Alzheimer Disease: A Functional MRI Study
por: Wang, Zhiqun, et al.
Publicado: (2012)

Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial
por: Ljubenkov, Peter A., et al.
Publicado: (2021)

Dopamine receptor D(4) (DRD(4)) polymorphisms with reduced functional potency intensify atrophy in syndrome-specific sites of frontotemporal dementia
por: Butler, P.M., et al.
Publicado: (2019)

Targeted manipulation of the sortilin–progranulin axis rescues progranulin haploinsufficiency
por: Lee, Wing C., et al.
Publicado: (2014)

The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment
por: Meles, Sanne K, et al.
Publicado: (2017)

Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease*
por: Desikan, Rahul S., et al.
Publicado: (2009)

MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer’s Disease
por: McKeever, Paul M., et al.
Publicado: (2018)

Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation
por: Chang, Michael C., et al.
Publicado: (2017)

Automatic morphometry in Alzheimer's disease and mild cognitive impairment()()
por: Heckemann, Rolf A., et al.
Publicado: (2011)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
por: Chalermpalanupap, Termpanit, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b5agcirqhlk8hqdvrd5n11b5ur